Zeke Capital Advisors, LLC Bio Sig Technologies, Inc. Transaction History

Zeke Capital Advisors, LLC

$1.53 Billion
Q4 2022

A detailed history of Zeke Capital Advisors, LLC transactions in Bio Sig Technologies, Inc. stock. As of the latest transaction made, Zeke Capital Advisors, LLC holds 70,866 shares of BSGM stock, worth $24,803. This represents 0.0% of its overall portfolio holdings.

Number of Shares

70,866

Previous 70,866 -0.0%

Holding current value

$24,803

Previous $45,000 35.56%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.63 - $1.22 $53,787 - $104,159	-85,377 Reduced 54.64%	70,866 $47,000
Q4 2021 Feb 14, 2022	SELL	$2.18 - $3.93 $99,288 - $178,991	-45,545 Reduced 22.57%	156,243 $348,000
Q3 2021 Nov 15, 2021	BUY	$2.71 - $4.35 $135,930 - $218,191	50,159 Added 33.08%	201,788 $601,000
Q1 2021 Apr 21, 2021	SELL	$3.99 - $5.53 $418,950 - $580,650	-105,000 Reduced 40.92%	151,629 $654,000
Q3 2020 Nov 09, 2020	BUY	$4.79 - $9.1 $191,600 - $364,000	40,000 Added 18.46%	256,629 $1.27 Million

Q2 2020 Jul 21, 2020	SELL	$3.61 - $11.84 $36,100 - $118,400	-10,000 Reduced 4.41%	216,629 $1.56 Million
Q1 2020 Apr 24, 2020	BUY	$2.56 - $6.14 $76,800 - $184,200	30,000 Added 15.26%	226,629 $950,000
Q4 2019 Jan 17, 2020	BUY	$5.78 - $8.11 $41,928 - $58,829	7,254 Added 3.83%	196,629 $1.16 Million
Q2 2019 Jul 24, 2019	SELL	$5.92 - $9.47 $106,708 - $170,696	-18,025 Reduced 8.69%	189,375 $1.78 Million
Q1 2019 Apr 29, 2019	SELL	$4.12 - $7.23 $20,600 - $36,150	-5,000 Reduced 2.35%	207,400 $1.27 Million
Q4 2018 Feb 11, 2019	SELL	$3.65 - $5.54 $362,080 - $549,568	-99,200 Reduced 31.84%	212,400 $907,000
Q3 2018 Nov 08, 2018	BUY	$4.1 - $7.5 $1.28 Million - $2.34 Million	311,600 New	311,600 $2.01 Million

Others Institutions Holding BSGM

# of Institutions

Shares Held

88.5K

Call Options Held

Put Options Held

View Full List

About BioSig Technologies, Inc.

Ticker BSGM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,814,400
Market Cap $15.7M
Description
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal ...

More about BSGM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zeke Capital Advisors, LLC with notifications on news.

Account

Zeke Capital Advisors, LLC Bio Sig Technologies, Inc. Transaction History